Antidepressant use may be linked to increased risk of weight gain
Prolonged use of antidepressants may lead to increased risk of weight gain...
List view / Grid view
Prolonged use of antidepressants may lead to increased risk of weight gain...
New research points to the important role that benzodiazepines may have in depression...
Major international study – comprising largest amount of unpublished data to date – has found that antidepressants are more effective than placebos for short-term treatment of acute depression in adults.
In a bid to maximise the effectiveness of treatment for patients, doctors have been using predictive models. New research finds that accessing data from electronic medical records could greatly benefit this practice.
The FDA has approved the first drug in the U.S. with a digital ingestion tracking system that records that the medication was taken...
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain...
5 January 2017 | By Niamh Marriott, Digital Editor
Amorsa has announced a research, option and license agreement with Janssen to develop and commercialise a novel small molecule drug candidate for depression...
3 October 2016 | By Niamh Louise Marriott, Digital Content Producer
People with the autoimmune disease, psoriasis, also report that they face discrimination, humiliation, and mental illness...
16 August 2016 | By Janssen
Following succesful phase II trials, the FDA have granted a Breakthrough Therapy Designation for esketamine, an investigational antidepressant medication...
12 August 2016 | By Niamh Louise Marriott, Digital Content Producer
Searching for answers through a series of biochemical tests, the scientists discovered that the patient had a cerebrospinal fluid deficiency in biopterin, a protein involved in the synthesis of several brain signalling chemicals called neurotransmitters. After receiving an analogue of biopterin to correct the deficiency, the patient's depression symptoms largely…
21 February 2011 | By Roche
Role will focus on disorders such as schizophrenia, neurodegeneration, treatment-resistant depression & neurodevelopment...